Propanc Biopharma Files S-1/A

Ticker: PPCB · Form: S-1/A · Filed: Apr 8, 2025 · CIK: 1517681

Propanc Biopharma, Inc. S-1/A Filing Summary
FieldDetail
CompanyPropanc Biopharma, Inc. (PPCB)
Form TypeS-1/A
Filed DateApr 8, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, pharmaceutical, corporate-update

TL;DR

Propanc Biopharma dropped an S-1/A on 4/8/25. Check financials.

AI Summary

Propanc Biopharma, Inc. filed an S-1/A on April 8, 2025, detailing its business and financial status. The company, incorporated in Delaware, operates in the pharmaceutical preparations sector. Its fiscal year ends on June 30, and its principal executive offices are located in Camberwell, Victoria, Australia.

Why It Matters

This filing provides updated information for investors and the public regarding Propanc Biopharma's corporate structure, financial health, and business operations.

Risk Assessment

Risk Level: medium — S-1/A filings often indicate a company is preparing for significant corporate actions like stock offerings or major disclosures, which can carry inherent investment risks.

Key Numbers

  • 20250408 — Filing Date (Date the S-1/A was filed)
  • 0630 — Fiscal Year End (Indicates the end of the company's financial reporting year)

Key Players & Entities

  • Propanc Biopharma, Inc. (company) — Filer of the S-1/A
  • 0001641172-25-003278 (dollar_amount) — Accession Number for the filing
  • 333-282886 (dollar_amount) — SEC File Number
  • 25823083 (dollar_amount) — Film Number
  • 302/6 BUTLER STREET (dollar_amount) — Business Street Address
  • CAMBERWELL, VICTORIA (dollar_amount) — Business City and State
  • 61-03-9882-0780 (dollar_amount) — Business Phone Number
  • Propanc Health Group Corp (company) — Former Company Name

FAQ

What is the primary purpose of this S-1/A filing by Propanc Biopharma, Inc.?

The S-1/A filing provides updated information about Propanc Biopharma, Inc.'s business, financial condition, and any proposed securities offerings or other material corporate changes.

When was this S-1/A filing submitted to the SEC?

The filing was submitted on April 8, 2025.

What industry does Propanc Biopharma, Inc. operate in?

Propanc Biopharma, Inc. operates in the Pharmaceutical Preparations sector, with SIC code 2834.

Where are Propanc Biopharma, Inc.'s principal business offices located?

The company's business address is listed as 302/6 Butler Street, Camberwell, Victoria, C3, 3124.

What was Propanc Biopharma, Inc.'s former company name?

The company was formerly known as Propanc Health Group Corp, with a name change date of April 8, 2011.

Filing Details

This Form S-1/A (Form S-1/A) was filed with the SEC on April 8, 2025 regarding Propanc Biopharma, Inc. (PPCB).

View full filing on EDGAR

View Full Filing

View this S-1/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.